Lectenz Bio accepted to NIH I-Corps program

Lectenz Bio has been accepted to the National Institute of Health (NIH) I-Corps program for SBIR phase I awardees. The goal of the program is to accelerate the development and commercialization of innovative technologies from companies currently funded by SBIR awards. Accepted companies are provided hands-on entrepreneurship training targeted towards customer discovery.